361: Superior disease-free survival in acute myelogenous leukemia/myelodysplastic syndrome receiving reduced-intensity allogeneic hematopoietic stem cell transplantation from unrelated donors using fludarabine, busulfan, and total lymphoid irradiation
Year: 2007
Type: article
Abstract: Reduced-intensity stem cell transplantation (RIST) from unrelated donors (UD) is shown to be feasible treatment option for acute myelogenous leukemia/myelodysplastic syndrome (AML/MDS). Although morbidity and mortality from graft-versus-host disease (GVHD) may be still significant, transplant from UD may carry more potent graft-versus-leukemia (GVL) effect.
Institution: University of Michigan
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2139980220